Cassier, Philippe A.
Navaridas, Raul http://orcid.org/0000-0003-1622-5311
Bellina, Melanie
Rama, Nicolas http://orcid.org/0000-0003-1614-7755
Ducarouge, Benjamin http://orcid.org/0000-0002-6701-0508
Hernandez-Vargas, Hector http://orcid.org/0000-0001-6045-2103
Delord, Jean-Pierre
Lengrand, Justine
Paradisi, Andrea http://orcid.org/0000-0003-2218-3859
Fattet, Laurent http://orcid.org/0000-0001-5152-4937
Garin, Gwenaële
Gheit, Hanane
Dalban, Cecile
Pastushenko, Ievgenia
Neves, David
Jelin, Remy
Gadot, Nicolas
Braissand, Nicolas
Léon, Sophie
Degletagne, Cyril
Matias-Guiu, Xavier
Devouassoux-Shisheboran, Mojgan
Mery-Lamarche, Eliane
Allard, Justine
Zindy, Egor
Decaestecker, Christine
Salmon, Isabelle
Perol, David
Dolcet, Xavi
Ray-Coquard, Isabelle http://orcid.org/0000-0003-2472-8306
Blanpain, Cédric http://orcid.org/0000-0002-4028-4322
Bernet, Agnès http://orcid.org/0000-0002-8260-9711
Mehlen, Patrick http://orcid.org/0000-0003-1743-5417
Article History
Received: 22 April 2022
Accepted: 23 June 2023
First Online: 2 August 2023
Competing interests
: A.B. and P.M. declare a conflict of interest as founders and shareholders of NETRIS Pharma. D.N., B.D., M.B., J.L. and P.M. declare a conflict of interest as employees of NETRIS Pharma. A.B., A.P. and N.R. declare a conflict of interest as consultants for NETRIS Pharma. No patent has been filed based on this study. The NP137 patent is fully owned by NETRIS Pharma and none of the authors are inventors. The remaining authors declare no competing interests.